0.99 USD
▲+0.01+0.64%
盘后 1.32 0.00%
2026-09-16
市值
$23.95M
市盈率
—
EPS
-0.89
股息率
—
52 周区间
0.90 – 8.49
成交量
194.94K
Beta
0.96
目标价
11.68
52W 低 0.9052W 高 8.49
价格走势
公司简介
Actuate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancers in the United States. The company’s lead product candidate is elraglusib injection, a glycogen synthase kinase-3 inhibitor that is in Phase 2 trial to treat metastatic pancreatic ductal adenocarcinoma. It also develops elraglusib, which is in Phase 1/2 trial for the treatment of refractory pediatric malignancies, including Ewing sarcoma, as well as neuroblastoma and pediatric leukemias. The company was formerly known as Apothe...